跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,783 条关于
“Guard Therapeutics”
全部
16,783
临床试验
3,676
药物
3,127
机构
1,130
资讯
8,850
2年前
First Patient Dosed in Guard Therapeutics' Phase 2b Study POINTER
11个月前
Guard Therapeutics' RMC-035 Fails Phase 2b POINTER Trial Despite Earlier Positive Results
去年
Guard Therapeutics Announces SEK 150M Rights Issue to Advance Kidney Protection Drug Development
去年
Guard Therapeutics' POINTER Study Reaches 25% Enrollment Milestone
2年前
Guard Therapeutics' RMC-035 Shows Kidney-Protective Effect in Phase 2 Trial
去年
Guard Therapeutics Doses First European Patient in Phase 2b POINTER Study of RMC-035 for Kidney Protection
2年前
GUARD-AF Trial: iRhythm's Zio XT Patch Increases AF Detection in Primary Care
去年
Philikos Initiates Phase 1/2 Trial of T-Guard for Diffuse Cutaneous Systemic Sclerosis
去年
Boston Scientific Resumes Enrollment in AVANT GUARD Atrial Fibrillation Trial
去年
Aptamer and Invizius Partner to Develop Next-Generation Complement System Therapies Using Synthetic Binders
第 1 页,共 885 页
上一页
下一页